PF06260933

  Cat. No.:  DC10496   Featured
Chemical Structure
1811510-56-1
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
PF 06260933 is a potent and selective MAP4K4 inhibitor (IC50 value 3.7 nM for MAP4K4 a.k.a. HGK or ZC1) with suitable PK properties in mouse to be used as a tool in an in vivo model of diabetes, vascular inflammation and atherosclerosis.
Cas No.: 1811510-56-1
Chemical Name: PF-06260933
Synonyms: PF-06260933;5-(4-Chlorophenyl)-[3,3']bipyridinyl-6,6'-diamine;5-(4-Chlorophenyl)-[3,3'-bipyridine]-6,6'-diamine;TQR1219;BCP28968;BDBM50134771;s6499;PF6260933;PF06260933; PF 06260933;5-(6-aminopyridin-3-yl)-3-(4-chlorophenyl)pyridin-2-amine
SMILES: ClC1C=CC(=CC=1)C1C(N)=NC=C(C2C=NC(=CC=2)N)C=1
Formula: C16H13ClN4
M.Wt: 296.75422167778
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: PF 06260933 is a potent and selective MAP4K4 inhibitor (IC50 value 3.7 nM for MAP4K4 a.k.a. HGK or ZC1) with suitable PK properties in mouse to be used as a tool in an in vivo model of diabetes, vascular inflammation and atherosclerosis. Robustly prevented TNF-α-mediated endothelial permeability in vitro, similar to MAP4K4 knockdown, and without alteration of plasma lipid content.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC10496 PF06260933 PF 06260933 is a potent and selective MAP4K4 inhibitor (IC50 value 3.7 nM for MAP4K4 a.k.a. HGK or ZC1) with suitable PK properties in mouse to be used as a tool in an in vivo model of diabetes, vascular inflammation and atherosclerosis.
DC10546 GNE-495 GNE-495 is a potent and Selective MAP4K4 Inhibitor with IC50 of 3.7 nM.
X